METHYLATION OF NOREPINEPHRINE AND ALPHA-METHYLNOREPINEPHRINE IN BRAIN

[1] AXELROD J, 1962, J BIOL CHEM, V237, P1657

[2] BEART PM, 1979, CLIN EXP PHARMACOL P, V6, P226

[3] ADRENALINE DEPLETION IN THE HYPOTHALAMUS OF THE RAT AFTER CHRONIC ALPHA-METHYLDOPA [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1981, 8 (01) : 25 - 31

[4] BOLME P, 1975, CENTRAL ACTION DRUGS, P61

[5] CANTONI GL, 1979, TRANSMETHYLATION, P155

[6] IMPORTANCE OF NEW CATECHOLAMINE PATHWAYS IN CONTROL OF BLOOD-PRESSURE [J]. CLINICAL AND EXPERIMENTAL HYPERTENSION, 1981, 3 (03) : 393 - 416

[7] PROPERTIES OF 8,9-DICHLORO-2,3,4,5-TETRAHYDRO-1H-2-BENZAZEPINE, AN INHIBITOR OF NOREPINEPHRINE N-METHYLTRANSFERASE [J]. BIOCHEMICAL PHARMACOLOGY, 1981, 30 (11) : 1345 - 1352

[8] FULLER RW, 1980, RES COMMUN CHEM PATH, V27, P485

[9] A MICROMETHOD FOR ASSAY OF PHENETHANOLAMINE N-METHYL TRANSFERASE [J]. ANALYTICAL BIOCHEMISTRY, 1966, 16 (02) : 349 - &

[10] FUXE K, 1975, CENTRAL ACTION DRUGS, P8

[1] AXELROD J, 1962, J BIOL CHEM, V237, P1657

[2] BEART PM, 1979, CLIN EXP PHARMACOL P, V6, P226

[3] ADRENALINE DEPLETION IN THE HYPOTHALAMUS OF THE RAT AFTER CHRONIC ALPHA-METHYLDOPA [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1981, 8 (01) : 25 - 31

[4] BOLME P, 1975, CENTRAL ACTION DRUGS, P61

[5] CANTONI GL, 1979, TRANSMETHYLATION, P155

[6] IMPORTANCE OF NEW CATECHOLAMINE PATHWAYS IN CONTROL OF BLOOD-PRESSURE [J]. CLINICAL AND EXPERIMENTAL HYPERTENSION, 1981, 3 (03) : 393 - 416

[7] PROPERTIES OF 8,9-DICHLORO-2,3,4,5-TETRAHYDRO-1H-2-BENZAZEPINE, AN INHIBITOR OF NOREPINEPHRINE N-METHYLTRANSFERASE [J]. BIOCHEMICAL PHARMACOLOGY, 1981, 30 (11) : 1345 - 1352

[8] FULLER RW, 1980, RES COMMUN CHEM PATH, V27, P485

[9] A MICROMETHOD FOR ASSAY OF PHENETHANOLAMINE N-METHYL TRANSFERASE [J]. ANALYTICAL BIOCHEMISTRY, 1966, 16 (02) : 349 - &

[10] FUXE K, 1975, CENTRAL ACTION DRUGS, P8